RFL - Rafael Holdings, Inc. logo

Rafael Holdings, Inc.

RFL

Rafael Holdings, Inc. invests in and develops clinical and early-stage pharmaceutical companies and medical devices, focusing on therapies for cancer and rare genetic disorders, including Niemann-Pick Disease Type C1, while also creating surgical instruments.

🏗️ Real Estate NYSE Listed 2018 $ USD
$1,000 invested 5 years ago →$44today

Score Overview

1 Year
Score
Net Growth-6.66%
Net TrendShrank
Net Income Consistency—
Rev Growth6.87%
Rev TrendGrew
Revenue Consistency—
5 Years
Score3.9
Net Growth-32.63%
Net Trend40%
Net Income Consistency—
Rev Growth22.19%
Rev Trend60%
Revenue Consistency—
All Time
Score
Net Growth-179.45%
Net Trend38%
Net Income Consistency
Rev Growth-77.58%
Rev Trend50%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Rafael Holdings, Inc. has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 1 year of fundamentals. RFL does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-30
$ 1.32—
1 Year2025-09-30
$ 1.36-2.94%
5 Years2021-09-30
$ 30.31-95.64%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 980K-$ 32M$ 30M
2025$ 917K-$ 30M$ 52M
2024$ 637K-$ 34M$ 65M
2023$ 279K-$ 1M$ 79M
2022$ 410K-$ 124M$ 63M
2021$ 802K-$ 24M$ 7M
2020$ 4M-$ 10M$ 6M
2019$ 4M-$ 4M$ 12M
IPO2018$ 4M-$ 11M$ 40M
RFL - Rafael Holdings, Inc. logo

Rafael Holdings, Inc. fundamental performance

Between 2020 and 2025, revenue declined from $ 4M to $ 917K and net income went from -$ 10M to -$ 30M. Revenue increased in 3 of those 5 years; net income in 2.

Rafael Holdings, Inc. currently holds a 5-year HDB Score of 3.9 out of 10. How the HDB Score is calculated.

Membership

Explore RFL with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,814 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies